Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome (a Double-blind Placebo-parallel Group Trial)
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2018
At a glance
- Drugs Ivabradine (Primary)
- Indications Postural orthostatic tachycardia syndrome
- Focus Therapeutic Use
- Acronyms POTS
- 22 Oct 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
- 22 Oct 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Feb 2019.
- 13 Mar 2018 The dosage of the drug has changed from 1 pill once a day to 1 pill twice a day